Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth

First Page		Document Content
Date: 2014-04-28 02:52:10 Complement system Nanomedicine Alternative complement pathway Nanotoxicology Anaphylatoxin Nanoparticle C3a Classical complement pathway Chemistry Biology		Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth Add to Reading List Source URL: pharmacy.ku.dk Download Document from Source Website File Size: 1,32 MB Share Document on Facebook

	Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth DocID: 1r05x - View Document
	C3 C3A   Harlow – Hammond Street MONDAYS TO FRIDAYS DocID: 1psRu - View Document
	MULTISCREENTM STABLE CELL LINE HUMAN RECOMBINANT C3A RECEPTOR Data sheet PRODUCT INFORMATION DocID: 1kLnR - View Document
	C3A Calls and Concepts February, \| 3/4 Mix 1/4 \| 3/4 the Deucey 1/4 \| 3/4 Wheel the Ocean \| Sea DocID: 1kjx2 - View Document
	Syddansk Universitet HepG2/C3A 3D spheroids exhibit stable physiological functionality for at least 24 days after recovering from trypsinisation Wrzesinski, Krzysztof; Magnone, Maria Chiara; Visby hansen, Line; Kruse, M DocID: 1bvNh - View Document